Unraveling the Molecular Jam: How Crowding Shapes Protein Aggregation in Neurodegenerative Disorders

Area of Science:

• Biochemistry
• Cell Biology
• Neuroscience

Background:

• Protein misfolding and aggregation are central to neurodegenerative diseases.
• The cellular environment, or macromolecular crowding, influences protein aggregation.
• This crowding affects pathological protein aggregation in diseases like Alzheimer's, Parkinson's, and Huntington's.

Purpose of the Study:

• To review recent studies on the effects of macromolecular crowding on protein aggregation.
• To summarize how crowding agents alter aggregation kinetics, stability, and morphology.
• To discuss the molecular mechanisms by which crowding influences amyloidogenic aggregation.

Main Methods:

• Review of existing literature on macromolecular crowding and protein aggregation.
• Analysis of studies using various crowding agents (polysaccharides, PEG, BSA, lysozyme).
• Examination of aggregation of amyloidogenic peptides and proteins (amylin, huntingtin, tau, α-synuclein, prion, amyloid-β).

Main Results:

• Crowding agents significantly alter aggregation kinetics, thermodynamic stability, and fibril morphology.
• Changes in protein conformation and nucleation mechanisms are observed under crowded conditions.
• Crowding influences the aggregation pathways of key proteins implicated in neurodegeneration.

Conclusions:

• Macromolecular crowding plays a critical role in modulating protein aggregation in neurodegenerative diseases.
• Understanding crowding effects is essential for elucidating disease pathologies.
• This knowledge can guide the identification of novel therapeutic targets for neurodegenerative disorders.